ArticleFrontiers in genetics2020
EnACP: An Ensemble Learning Model for Identification of Anticancer Peptides.
Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- ACP-EPC: an interpretable deep learning framework for anticancer peptide prediction utilizing pre-trained protein language model and multi-view feature extracting strategy.Molecular diversity · 2026Article
- Enhancing anticancer peptide discovery: A fusion-centric framework with conditional diffusion for prediction and generation.PLoS computational biology · 2026Article
- Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma.Oncology research · 2026Article
- Artificial intelligence-driven anticancer peptide discovery.iMetaOmics · 2025Review
- iACP-DPNet: a dual-pooling causal dilated convolutional network for interpretable anticancer peptide identification.Functional & integrative genomics · 2025Article
- Extended dipeptide composition framework for accurate identification of anticancer peptides.Scientific reports · 2024Article
- Integrating In Silico and In Vitro Approaches to Identify Natural Peptides with Selective Cytotoxicity against Cancer Cells.International journal of molecular sciences · 2024Article
- AMP-EBiLSTM: employing novel deep learning strategies for the accurate prediction of antimicrobial peptides.Frontiers in genetics · 2023Article
- ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides.International journal of molecular sciences · 2022Article
- Multi-feature Fusion Method Based on Linear Neighborhood Propagation Predict Plant LncRNA-Protein Interactions.Interdisciplinary sciences, computational life sciences · 2022Article
- ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information.Molecules (Basel, Switzerland) · 2022Article
- Active Semisupervised Model for Improving the Identification of Anticancer Peptides.ACS omega · 2021Article
- Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties.Scientific reports · 2021Article
- ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation.Frontiers in genetics · 2021Article
- Peptides with Dual Antimicrobial-Anticancer Activity: Strategies to Overcome Peptide Limitations and Rational Design of Anticancer Peptides.Molecules (Basel, Switzerland) · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As cancer remains one of the main threats of human life, developing efficient cancer treatments is urgent. Anticancer peptides, which could overcome the significant side effects and poor results of traditional cancer treatments, have become a new potential alternative these years. However, identifying anticancer peptides by experimental methods is time consuming and resource consuming, it is of great significance to develop effective computational tools to quickly and accurately identify potential anticancer peptides from amino acid sequences. For most current computational methods, feature representation plays a key role in their final successes. This study proposes a novel fast and accurate approach to identify anticancer peptides using diversified feature representations and ensemble learning method. For the feature representations, the information is encoded from multidimensional feature spaces, including sequence composition, sequence-order, physicochemical properties, etc. In order to better model the potential relationships of peptides, multiple ensemble classifiers, LightGBMs, are applied to detect the different feature sets at first. Then the obtained multiple outputs are used as inputs of the support vector machine classifier, which effectively identifies anticancer peptides. Experimental results on cross validation and independent test sets demonstrate that our method can achieve better or comparable performances compared with other state-of-the-art methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.